The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, such as the liver, lungs, and spleen. Nevertheless, Ali and Townsend note ...

Born in Mumbai, Reshma moved to the United States at the age of 11. She earned her medical degree from Boston University and ...

Some Boston public school students are spending their summer vacations learning and working at a global biotech company.

A cure for genetic heart conditions could reach trials in only 5 years, and it “rewrites” DNA. Experts explain the potential ...

Agios Pharmaceuticals gears up for a pivotal 2025 with key PYRUKYND milestones, including FDA decisions for thalassemia.

The choice of keeping your babys cord blood is a very personal one but it is also one of the few times where parents must be ...

Gene Therapy Market Gene therapy market surges on breakthroughs in genome editing, rising chronic & genetic disease cases, regulatory appro ...

Oregon will initially focus on providing lower-cost therapies for people living with sickle cell disease, a genetic blood ...

"We haven't yet achieved the mission of the NIH, which is research that improves the health and longevity of the American ...

The Centers for Medicare & Medicaid Services (“CMS”) recently released two proposed updates to Medicare payment rules that, if implemented, could ...

After decades of excruciating pain, a breakthrough sickle cell disease treatment made all the difference for one patient.

AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s Yokohama Technical Center.